FloQast Recognized by Inc. as One of America's Fastest Growing Private Companies for Third Consecutive Year 12-08-2025, 20:00

Azerion completes sale of Youda Games Portfolio to Playtika 28-08-2023, 15:06

Io Therapeutics, Inc., presented data from studies of IRX4204, the company’s phase II clinical development stage, highly selective third generation RXR nuclear receptor agonist compound, supporting its potential use for prevention and treatment of normal 10-07-2024, 07:00